Copyright
©The Author(s) 2022.
World J Gastrointest Pathophysiol. May 22, 2022; 13(3): 96-106
Published online May 22, 2022. doi: 10.4291/wjgp.v13.i3.96
Published online May 22, 2022. doi: 10.4291/wjgp.v13.i3.96
Table 1 Characteristics of patients with nonalcoholic fatty liver disease
| Patients (n) | 191 |
| Age (years old) | 62 (20-90) |
| Men (%) | 81 (42.4) |
| diabetes (%) | 75 (39.3) |
| HCC | 17 |
| EGV | 16 |
| Both HCC and EGV | 9 |
| AST (U/L) | 36 (13-208) |
| ALT (U/L) | 40 (10-214) |
| Platelet count (×109/L) | 207 (45-445) |
- Citation: Miura K, Maeda H, Morimoto N, Watanabe S, Tsukui M, Takaoka Y, Nomoto H, Goka R, Kotani K, Yamamoto H. Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities. World J Gastrointest Pathophysiol 2022; 13(3): 96-106
- URL: https://www.wjgnet.com/2150-5330/full/v13/i3/96.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v13.i3.96